Garry Menzel

Garry Menzel

Director/Board Member bij ADAPTIMMUNE THERAPEUTICS PLC

Vermogen: 537 011 $ op 31-03-2024

59 jaar
Health Technology
Consumer Services
Finance

Profiel

Dr. Garry E.
Menzel
is an Operating Partner at GHO Capital Partners LLP, an Independent Non-Executive Director at Adaptimmune Therapeutics Plc, an Independent Director at Stoke Therapeutics, Inc., an Independent Director at Black Diamond Therapeutics, Inc., a Member-National Board at Epilepsy Foundation and a Principal at Royal College of Art.
He is on the Board of Directors at Adaptimmune Therapeutics Plc, Stoke Therapeutics, Inc., Black Diamond Therapeutics, Inc. and Epilepsy Therapy Project.
Dr. Menzel was previously employed as a Chief Executive Officer by TCR2 Therapeutics, Inc., a Chief Strategy Officer by Pronutria Biosciences, Inc., a Chief Financial Officer by DaVita HealthCare Partners, Inc., a Chief Operating Officer by Regulus Therapeutics, Inc., a Managing Director by Credit Suisse Group, a Managing Director by The Goldman Sachs Group, Inc., a Consultant by Bain & Co., Inc., a Director-Emeritus by Institute for Systems Biology, and a Research Assistant by Smithkline Beecham Plc.
He received his undergraduate degree from Imperial College London, an MBA from Stanford Graduate School of Business and a doctorate degree from the University of Cambridge.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
16-05-2023 76 644 ( 0.15% ) 388 585 $ 31-03-2024
10-07-2023 563 522 ( 0.10% ) 148 426 $ 31-03-2024
01-09-2023 0 ( -.--% ) - $ 31-03-2024

Actieve functies van Garry Menzel

BedrijvenFunctieBegin
BLACK DIAMOND THERAPEUTICS, INC. Director/Board Member 01-01-2014
STOKE THERAPEUTICS, INC. Director/Board Member 13-08-2020
ADAPTIMMUNE THERAPEUTICS PLC Director/Board Member 01-06-2023
Corporate Officer/Principal 01-01-2003
Epilepsy Therapy Project Director/Board Member -
Royal College of Art Corporate Officer/Principal 17-03-2010
Private Equity Investor 23-04-2024
Alle actieve functies van Garry Menzel

Eerdere bekende functies van Garry Menzel

BedrijvenFunctieEinde
TCR2 THERAPEUTICS INC. Chief Executive Officer 01-01-2023
AXCA HEALPAR Corporate Officer/Principal 01-09-2016
░░░░░░ ░░░░ ░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░ ░░░░░ ░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Ervaring van Garry Menzel in detail bekijken

Opleiding van Garry Menzel

Imperial College London Undergraduate Degree
University of Cambridge Doctorate Degree
Stanford Graduate School of Business Masters Business Admin

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Garry Menzel in detail bekijken

Connecties

100 +

Eerstegraads connecties

19

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven7
DAVITA INC.

Health Services

THE GOLDMAN SACHS GROUP, INC.

Finance

REGULUS THERAPEUTICS INC.

Health Technology

AXCA HEALPAR

Health Technology

STOKE THERAPEUTICS, INC.

Health Technology

BLACK DIAMOND THERAPEUTICS, INC.

Health Technology

ADAPTIMMUNE THERAPEUTICS PLC

Health Technology

Bedrijven in privébezit8

Health Technology

Finance

Commercial Services

Commercial Services

Commercial Services

Epilepsy Therapy Project

Health Technology

Finance

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Garry Menzel